Allurion Technologies Inc (OTCPK:ALUR)

Q3 2025 Allurion Technologies Inc Earnings Call Transcript

Nov 12, 2025 / 01:30 PM GMT

Release Date Price: $22.5 (+0.67%)

Transcript 10-Q8-K

Key Points

Positve

Allurion Technologies Inc (ALUR) has made significant progress in the FDA approval process for the Euron smart capsule, passing several critical milestones without any observations or Form 483 issued.
The company has successfully restructured its operations, resulting in a 29% decrease in operating expenses and a 22% reduction in operating loss compared to the previous year.
Allurion Technologies Inc (ALUR) is exploring innovative R&D projects, such as a drug-eluting balloon, which could revolutionize obesity therapy by addressing adherence challenges.
The company has strengthened its financial position by restructuring its balance sheet, exchanging outstanding debt for convertible preferred equity, and securing a private placement financing.
Allurion Technologies Inc (ALUR) is strategically focusing on accounts that offer comprehensive obesity management, which has shown potential for long-term growth and access to a steady supply of patients.

Negative

Revenue for the third quarter of 2025 was $2.7 million, a significant decrease from $5.4 million in the same period of 2024, primarily due to restructuring.
Gross profit margin decreased to 49% from 58% in the previous year, impacted by lower production volumes and restructuring costs.
The company experienced a reduction in sales and marketing expenses, which, while improving efficiency, may indicate a scaling back of promotional activities.
Research and development expenses decreased, which could suggest a slowdown in innovation or new product development.
Despite restructuring efforts, the company still reported a loss from operations of $9.6 million for the third quarter.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ALUR.N - Allurion Technologies Inc
Q3 2025 Allurion Technologies Inc Earnings Call
Nov 12, 2025 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and thank you for standing by. My name is Mark and I will be your conference operator today. At this time, I would like to welcome everyone to the Allurian 3rd quarter earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session.

If you would like to ask a question during this time, simply to press pardon, the number one on your telephone keypad.

And to withdraw your question, press one again.

Thank you. Now I would like to turn the call over to Tara Brady. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.